Wells Fargo Is Well-Positioned for the Upcoming Year; We're Increasing FVE to $65
We are increasing our fair value estimate for Wells Fargo to $65 per share from $60 per share after incorporating the latest results. This fair value estimate is equivalent to 1.6 times the reported ...
Haemonetics stock touches 52-week low at $69.2 amid challenges
Haemonetics Corporation (NYSE:HAE), a global healthcare company with a market capitalization of $3.48 billion, has seen its stock price touch a 52-week low, reaching $69.2. According to InvestingPro ...